APA

Reichardt P., Schlemmer M., Delgado Perez J. R., Papai Z., Prausova J., Melichar B., Fumagalli E., Barone C., Bauer S., Pustowka A., Crippa S., Castellana R., Quiering C. & Le Cesne A. (20200413). Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting. : Oncology research and treatment.

Chicago

Reichardt Peter, Schlemmer Marcus, Delgado Perez Juan R, Papai Zsuzsanna, Prausova Jana, Melichar Bohuslav, Fumagalli Elena, Barone Carlo, Bauer Sebastian, Pustowka Anette, Crippa Stefania, Castellana Ramon, Quiering Claudia and Le Cesne Axel. 20200413. Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting. : Oncology research and treatment.

Harvard

Reichardt P., Schlemmer M., Delgado Perez J. R., Papai Z., Prausova J., Melichar B., Fumagalli E., Barone C., Bauer S., Pustowka A., Crippa S., Castellana R., Quiering C. and Le Cesne A. (20200413). Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting. : Oncology research and treatment.

MLA

Reichardt Peter, Schlemmer Marcus, Delgado Perez Juan R, Papai Zsuzsanna, Prausova Jana, Melichar Bohuslav, Fumagalli Elena, Barone Carlo, Bauer Sebastian, Pustowka Anette, Crippa Stefania, Castellana Ramon, Quiering Claudia and Le Cesne Axel. Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting. : Oncology research and treatment. 20200413.